NAVKIDS2 trial: a multi-centre, waitlisted randomised controlled trial of a patient navigator intervention in children with chronic kidney disease — statistical analysis plan and update to the protocol

Anita van Zwieten(The University of Sydney), Germaine Wong(Children's Hospital at Westmead), Elizabeth Ryan(Cancer Research And Biostatistics), Michelle Irving(New South Wales Department of Health), Luke Macauley(Kidney Health Australia), Rabia Khalid(The University of Sydney), Fiona Mackie, Steven McTaggart, Nicholas Larkins, Deirdré Hahn(Children's Hospital at Westmead), Siah Kim, Donna Reidlinger(Translational Research Institute), Allison Tong(The University of Sydney), Jonathan C. Craig(Flinders University), Chandana Guha(The University of Sydney), Seán Kennedy(Environmental Protection Agency), David W. Johnson(Hennepin County), Armando Teixeira‐Pinto(The University of Sydney), Hugh J. McCarthy(University of Bristol), Shilpanjali Jesudason(South Australia Pathology), Alistair R. Mallard(The University of Queensland), Reginald Woodleigh(Prostate Cancer Foundation of Australia), Anna Francis(Children's Health Queensland Hospital and Health Service), Patrina Caldwell(Children's Hospital at Westmead), Kirsten Howard(The University of Sydney), Stephen I. Alexander(University of South Australia), Amélie Bernier-Jean(Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal), Martin Howell(UNSW Sydney), Carmel M. Hawley(The University of Queensland), Julie Varghese(The University of Queensland), Amanda Walker(Royal Children's Hospital), Elaine Pascoe(The University of Queensland), Simon Carter(Royal Children's Hospital), Liza A. Vergara(The University of Queensland), Charani Kiriwandeniya(The University of Queensland)
Trials
September 29, 2022
Cited by 4


Related Papers